26 related articles for article (PubMed ID: 10613605)
21. [A fundamentally new cytostatic: a methylhydrazine derivative (Natulan)].
Hansen MM; Hertz H
Ugeskr Laeger; 1966 Mar; 128(11):313-6. PubMed ID: 5331165
[No Abstract] [Full Text] [Related]
22. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
23. NCI's anticancer drug screening program may not be selecting for clinically active compounds.
Brown JM
Oncol Res; 1997; 9(5):213-5. PubMed ID: 9306428
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumor action of alkyl-lysophospholipids (Review).
Berdel WE; Bausert WR; Fink U; Rastetter J; Munder PG
Anticancer Res; 1981; 1(6):345-52. PubMed ID: 7046622
[TBL] [Abstract][Full Text] [Related]
25. [Segidrin: a new-type antineoplastic agent].
Filov VA
Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
[No Abstract] [Full Text] [Related]
26. [From the aspect of pre-clinical study of new anticancer candidate compounds].
Tsukagoshi S
Gan To Kagaku Ryoho; 1995 Apr; 22(5):599-602. PubMed ID: 7717709
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
